Elevated Triiodothyromne and Dextrothyroxine Levels: A Potential Cause of latrogenic Hyperthyroidism von CIHAK, ROBERT W., BEARY, F. DAVID

Volltext

Elevated triiodothyronine and dextrothyroxine levels: a potential cause of iatrogenic hyperthyroidism von Cihak, R W, Beary, F D

Volltext

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] von Spector, Tim D, Conaghan, Philip G, Buckland-Wright, J Christopher, Garnero, Patrick, Cline, Gary A, Beary, John F, Valent, David J, Meyer, Joan M

Volltext

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis von Delmas, Pierre D, McClung, Michael R, Zanchetta, José R, Racewicz, Artur, Roux, Christian, Benhamou, Claude-Laurent, Man, Zulema, Eusebio, Rachelle A, Beary, John F, Burgio, David E, Matzkin, Ellen, Boonen, Steven

Volltext

Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlle... von Ste-Marie, Louis-Georges, MD, Brown, Jacques P., MD, Beary, John F., MD, Matzkin, Ellen, MD, Darbie, Lynn M., MS, Burgio, David E., PhD, Racewicz, Artur J., MD

Volltext

U.S. drug and biologic approvals in 1996 von Beary III, John F., Robillard, Lara E., Woollett, Gillian R., Siegfried, John D., White, Thomas X., Shriver, David A.

Volltext